India Life Sciences Fund IV is a private equity fund based in Gandhinagar, Gujarat, India. According to its most recent Form D, filed Jun 24, 2024, it has sold $115,640,000 of interests to 16 investors since its first sale in Jul 2023. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Hariharnath Buggana.
- Total raised
- $115,640,000Cumulative sales reported on Form D
- Investors
- 16
- First sale
- Jul 6, 2023
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Hariharnath Buggana
- Latest Form D
- Jun 24, 2024
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Jun 24, 2024 | Form D/A (amendment) | $115,640,000 | 16 | SEC.gov ↗ |
| Jun 28, 2023 | Form D | $0 | 0 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jun 28, 2023. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Related vehicles with the same name (2)
| Vehicle | Total raised | Investors | Latest Form D |
|---|---|---|---|
| India Life Sciences Fund IV (this page) | $115,640,000 | 16 | Jun 24, 2024 |
| INDIA LIFE SCIENCES FUND IV DOMESTIC | $1,606,024 | 3 | Apr 22, 2025 |
Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 2 filings share this fund's name apart from such vehicle words or a series letter, which usually means they are versions of one fund. Grouped by AltMountain from the names on the filings alone, so the list may be incomplete or include a separate fund with a near-identical name; amounts are each vehicle's own filing and should not be added together, because a feeder's money can also be counted in its master fund. Source: SEC Form D filings.
Questions about India Life Sciences Fund IV
What is the minimum investment for India Life Sciences Fund IV?
India Life Sciences Fund IV's latest Form D, filed Jun 24, 2024, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in India Life Sciences Fund IV?
India Life Sciences Fund IV is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has India Life Sciences Fund IV raised?
India Life Sciences Fund IV reports $115,640,000 sold from 16 investors on its Form D filed Jun 24, 2024. This is cumulative sales since the offering began, not current assets or performance.
Where is India Life Sciences Fund IV based?
India Life Sciences Fund IV is based in Gandhinagar, Gujarat, India.
When did India Life Sciences Fund IV launch?
India Life Sciences Fund IV reports its first sale in Jul 2023.
Size compared with every private equity fund
Raised more than 94% of the 16 private equity funds based in India, and more than 75% of all 8,950 that report sales.